Literature DB >> 26394495

Fecal Microbiota Transplantation for Clostridium difficile-Associated Diarrhea.

Nathaniel A Cohen, Ronen Ben Ami, Hanan Guzner-Gur, Moshe E Santo, Zamir Halpern, Nitsan Maharshak.   

Abstract

Clostridium difficile-associated diarrhea is a problem most hospital-based physicians will face in their career. This review aims to refresh current knowledge with regard to Clostridium difficile infection and bring physicians up to date with the latest developments in the growing field of fecal microbiota transplantation, the benefits it offers, and the promise this and other developments hold for the future.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26394495

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  4 in total

1.  Early Results of Fecal Microbial Transplantation Protocol Implementation at a Community-based University Hospital.

Authors:  Rodrigo Duarte-Chavez; Thomas R Wojda; Thomas B Zanders; Berhanu Geme; Gloria Fioravanti; Stanislaw P Stawicki
Journal:  J Glob Infect Dis       Date:  2018 Apr-Jun

Review 2.  The human gut microbiome in health: establishment and resilience of microbiota over a lifetime.

Authors:  Kacy Greenhalgh; Kristen M Meyer; Kjersti M Aagaard; Paul Wilmes
Journal:  Environ Microbiol       Date:  2016-07       Impact factor: 5.491

3.  Fecal microbiota transplantation research output from 2004 to 2017: a bibliometric analysis.

Authors:  Yan Li; Ziyuan Zou; Xiaohui Bian; Yushan Huang; Yanru Wang; Chen Yang; Jian Zhao; Lang Xie
Journal:  PeerJ       Date:  2019-02-20       Impact factor: 2.984

4.  Clostridium difficile fecal toxin level is associated with disease severity and prognosis.

Authors:  Nathaniel A Cohen; Tamar Miller; Wasef Na'aminh; Keren Hod; Amos Adler; Daniel Cohen; Hanan Guzner-Gur; Erwin Santo; Zamir Halpern; Yehuda Carmeli; Nitsan Maharshak
Journal:  United European Gastroenterol J       Date:  2017-12-21       Impact factor: 4.623
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.